HC Wainwright & Co. Reiterates Buy on Kodiak Sciences, Maintains $58 Price Target

HC Wainwright & Co. analyst Matthew Caufield has reiterated a Buy rating on Kodiak Sciences (NASDAQ: KOD) and maintained a price target of $58. This endorsement suggests confidence in the company's future performance.